메뉴 건너뛰기




Volumn 53, Issue 10, 2014, Pages 1434-1436

Ado-trastuzamab emtansine associated hyponatremia and intracranial hemorrhage

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; CHLORIDE; DEMECLOCYCLINE; DEXAMETHASONE; EXEMESTANE; INFUSION FLUID; LAPATINIB; NAVELBINE; SODIUM; SODIUM CHLORIDE; TAMOXIFEN; TRASTUZUMAB; TRASTUZUMAB EMTANSINE; ANTINEOPLASTIC AGENT; MAYTANSINE; MONOCLONAL ANTIBODY;

EID: 84911904525     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2014.920959     Document Type: Letter
Times cited : (6)

References (13)
  • 2
    • 0016724870 scopus 로고
    • Antim-itotic activity of the potent tumor inhibitor maytansine
    • Remillard S, Rebhun LI, Howie GA, Kupchan SM. Antim-itotic activity of the potent tumor inhibitor maytansine. Science 1975; 189: 1002-5.
    • (1975) Science , vol.189 , pp. 1002-1005
    • Remillard, S.1    Rebhun, L.I.2    Howie, G.A.3    Kupchan, S.M.4
  • 3
    • 3042748791 scopus 로고    scopus 로고
    • Recent developments in the maytansinoid antitumor agents
    • Cassady JM, Chan KK, Floss HG. Recent developments in the maytansinoid antitumor agents. Chem Pharm Bull 2004; 52: 1-26.
    • (2004) Chem Pharm Bull , vol.52 , pp. 1-26
    • Cassady, J.M.1    Chan, K.K.2    Floss, H.G.3
  • 5
    • 79952092706 scopus 로고    scopus 로고
    • Phase II study of the antibody drug conjugate trastuzumab-DM1 for the treatment of human epidermal growth factor receptor 2 (HER2)-positive breast cancer after prior HER2-directed therapy
    • Burris HA 3rd, Rugo HS, Vukelja SJ, Vogel CL, Borson RA, Limentani S, et al. Phase II study of the antibody drug conjugate trastuzumab-DM1 for the treatment of human epidermal growth factor receptor 2 (HER2)-positive breast cancer after prior HER2-directed therapy. J Clin Oncol 2011; 29: 398-405.
    • (2011) J Clin Oncol , vol.29 , pp. 398-405
    • Burris, H.A.1    Rugo, H.S.2    Vukelja, S.J.3    Vogel, C.L.4    Borson, R.A.5    Limentani, S.6
  • 6
    • 84902477569 scopus 로고    scopus 로고
    • Trastuzumab emtansine and stereotactic radiosurgery: An unexpected increase in clinically significant brain edema
    • Epub 2014 Feb 3
    • Carlson JA, Nooruddin Z, Rusthoven C, Elias A, Borges VF, Diamond JR, et al. Trastuzumab emtansine and stereotactic radiosurgery: An unexpected increase in clinically significant brain edema. Neuro Oncol Epub 2014 Feb 3.
    • Neuro Oncol
    • Carlson, J.A.1    Nooruddin, Z.2    Rusthoven, C.3    Elias, A.4    Borges, V.F.5    Diamond, J.R.6
  • 8
    • 34247346051 scopus 로고    scopus 로고
    • Prognostic significance of human epidermal growth factor receptor positivity for the development of brain metastasis after newly diagnosed breast cancer
    • Gabos Z, Sinha R, Hanson J, Chauhan N, Hugh J, Mackey JR, et al. Prognostic significance of human epidermal growth factor receptor positivity for the development of brain metastasis after newly diagnosed breast cancer. J Clin Oncol 2006; 24: 5658-63.
    • (2006) J Clin Oncol , vol.24 , pp. 5658-5663
    • Gabos, Z.1    Sinha, R.2    Hanson, J.3    Chauhan, N.4    Hugh, J.5    Mackey, J.R.6
  • 9
    • 33646869874 scopus 로고    scopus 로고
    • Identifying breast cancer patients at risk for central nervous system (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG)
    • Pestalozzi BC, Zahrieh D, Price KN, Holmberg SB, Lindtner J, Collins J, et al. Identifying breast cancer patients at risk for central nervous system (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG). Ann Oncol 2006; 17: 935-44.
    • (2006) Ann Oncol , vol.17 , pp. 935-944
    • Pestalozzi, B.C.1    Zahrieh, D.2    Price, K.N.3    Holmberg, S.B.4    Lindtner, J.5    Collins, J.6
  • 10
    • 0037301972 scopus 로고    scopus 로고
    • Survival of patients with metastatic breast carcinoma: Importance of prognostic markers of the primary tumor
    • Chang J, Clark GM, Allred DC, Mohsin S, Chamness G, Elledge RM. Survival of patients with metastatic breast carcinoma: Importance of prognostic markers of the primary tumor. Cancer 2003; 97: 545-53.
    • (2003) Cancer , vol.97 , pp. 545-553
    • Chang, J.1    Clark, G.M.2    Allred, D.C.3    Mohsin, S.4    Chamness, G.5    Elledge, R.M.6
  • 11
    • 0026059293 scopus 로고
    • Association of c-erbB-2 protein over-expression with high rate of cell proliferation, increased risk of visceral metastasis and poor long-term survival in breast cancer
    • Kallioniemi OP, Holli K, Visakorpi T, Koivula T, Helin HH, Isola JJ. Association of c-erbB-2 protein over-expression with high rate of cell proliferation, increased risk of visceral metastasis and poor long-term survival in breast cancer. Int J Cancer 1991; 49: 650-5.
    • (1991) Int J Cancer , vol.49 , pp. 650-655
    • Kallioniemi, O.P.1    Holli, K.2    Visakorpi, T.3    Koivula, T.4    Helin, H.H.5    Isola, J.J.6
  • 12
    • 84911874253 scopus 로고    scopus 로고
    • Genentech [cited 2014 Mar 12]
    • ® (ado-trastuzumab emtansine). [cited 2014 Mar 12]. Available from: http://www.gene.com/download/pdf/Kadcyla- DHCP%20letter.pdf.
    • (2013) ® (Ado-trastuzumab Emtansine)
  • 13
    • 84869508508 scopus 로고    scopus 로고
    • A phase 1 study of weekly dosing of trastuzumab emtansine (T-DM1) in patients with advanced human epidermal growth factor 2-positive breast cancer
    • Beeram M, Krop IE, Burris HA, Girish SR, Yu W, Lu MW, et al. A phase 1 study of weekly dosing of trastuzumab emtansine (T-DM1) in patients with advanced human epidermal growth factor 2-positive breast cancer. Cancer 2012; 118: 5733-40.
    • (2012) Cancer , vol.118 , pp. 5733-5740
    • Beeram, M.1    Krop, I.E.2    Burris, H.A.3    Girish, S.R.4    Yu, W.5    Lu, M.W.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.